| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.503 | 43.806 | 34.462 | 42.895 | 41.057 | 45.603 | 66.194 | 98.917 | 103.542 | 107.360 |
| Total Income - EUR | 39.503 | 43.806 | 39.496 | 43.110 | 41.057 | 45.603 | 66.194 | 98.917 | 103.581 | 107.360 |
| Total Expenses - EUR | 16.417 | 13.068 | 8.638 | 11.548 | 16.393 | 23.746 | 48.705 | 38.341 | 30.170 | 55.611 |
| Gross Profit/Loss - EUR | 23.087 | 30.738 | 30.858 | 31.562 | 24.664 | 21.857 | 17.489 | 60.576 | 73.410 | 51.749 |
| Net Profit/Loss - EUR | 21.902 | 29.423 | 28.791 | 30.763 | 24.008 | 21.508 | 16.941 | 59.538 | 72.478 | 49.005 |
| Employees | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Neuro Crist S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.551 | 7.274 | 4.292 | 13.250 | 8.328 | 131.946 | 146.619 | 193.017 | 188.608 | 253.973 |
| Current Assets | 49.850 | 32.098 | 68.970 | 54.262 | 78.794 | 86.616 | 124.611 | 141.272 | 156.966 | 161.710 |
| Inventories | 1.227 | 0 | 0 | 0 | 0 | 0 | 198 | 169 | 0 | 0 |
| Receivables | 48.021 | 32.078 | 67.746 | 54.223 | 78.200 | 86.321 | 75.916 | 132.803 | 160.187 | 162.583 |
| Cash | 602 | 20 | 1.224 | 39 | 594 | 295 | 48.498 | 8.300 | -3.221 | -873 |
| Shareholders Funds | 49.864 | 29.477 | 57.769 | 55.239 | 78.177 | 98.202 | 112.966 | 170.653 | 183.986 | 193.063 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.538 | 9.895 | 15.493 | 12.273 | 8.945 | 120.360 | 158.265 | 163.636 | 161.588 | 222.620 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Crist S.r.l.